Self-sampling in cervical cancer screening: Comparison of a brush-based and a lavage-based cervicovaginal self-sampling device

BMC Cancer

Volumn 16, Issue 1, 2016, Pages

  Karjalainen, Liisa ^a   Anttila, Ahti ^a   Nieminen, Pekka ^b   Luostarinen, Tapio ^a   Virtanen, Anni ^a  

^a FINNISH CANCER REGISTRY   (Finland)

^b JORVI HOSPITAL   (Finland)

Author keywords

Acceptability; Cervical cancer screening; HPV; Self sampling; Socio demographic factors

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BRUSH BASED CERVICOVAGINAL SELF-SAMPLING DEVICE; CANCER SCREENING; CERVICOVAGINAL SELF-SAMPLING DEVICE; CONTROLLED STUDY; FEMALE; FINN (CITIZEN); HUMAN; HUMAN TISSUE; LAVAGE BASED CERVICOVAGINAL SELF-SAMPLING DEVICE; MAJOR CLINICAL STUDY; PATIENT ATTITUDE; PATIENT COMFORT; PATIENT PARTICIPATION; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SAMPLING; SELF SAMPLING; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; CERVICAL INTRAEPITHELIAL NEOPLASIA; EARLY CANCER DIAGNOSIS; FINLAND; ISOLATION AND PURIFICATION; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRIDAE; PATHOGENICITY; PATHOLOGY; RISK FACTOR; SELF CARE; SOCIOECONOMICS; SPECIMEN HANDLING; VIROLOGY;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; EARLY DETECTION OF CANCER; FEMALE; FINLAND; HUMANS; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRIDAE; PATIENT ACCEPTANCE OF HEALTH CARE; RISK FACTORS; SELF CARE; SOCIOECONOMIC FACTORS; SPECIMEN HANDLING; SURVEYS AND QUESTIONNAIRES;

EID: 84960903758     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/s12885-016-2246-9     Document Type: Article

References (30)

1. Finnish Cancer Registry Statistics. Available at: www. cancerregistry.fi/statistics.
2. Lönnberg S, Anttila A, Luostarinen T, Nieminen P. Age-specific effectiveness of the finnish cervical cancer screening programme. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol. 2012;21(8):1354-61.
3. Lönnberg S, Nieminen P, Luostarinen T, Anttila A. Mortality audit of the finnish cervical cancer screening program. Int J Cancer J Int Cancer. 2013;132(9):2134-40.
4. Anttila A, Pukkala E, Söderman B, Kallio M, Nieminen P, Hakama M. Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963-1995: recent increase in cervical cancer incidence. Int J Cancer J Int Cancer. 1999;83(1):59-65.
5. Virtanen A, Anttila A, Luostarinen T, Nieminen P. Self-sampling versus reminder letter: effects on cervical cancer screening attendance and coverage in Finland. Int J Cancer J Int Cancer. 2011;128(11):2681-7.
6. Virtanen A, Nieminen P, Luostarinen T, Anttila A. Self-sample HPV tests as an intervention for nonattendees of cervical cancer screening in Finland: a randomized trial. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol. 2011;20(9):1960-9.
7. Eaker S, Adami H-O, Granath F, Wilander E, Sparén P. A large population-based randomized controlled trial to increase attendance at screening for cervical cancer. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol. 2004;13(3):346-54.
8. Wilson A, Leeming A. Cervical cytology screening: a comparison of two call systems. Br Med J (Clin Res Ed). 1987;295(6591):181-2.
9. Broberg G, Gyrd-Hansen D, Miao Jonasson J, Ryd M-L, Holtenman M, Milsom I, Strander B. Increasing participation in cervical cancer screening: offering a HPV self-test to long-term non-attendees as part of RACOMIP, a Swedish randomized controlled trial. Int J Cancer J Int Cancer. 2014;134(9):2223-30.
10. Gök M, Heideman DAM, van Kemenade FJ, Berkhof J, Rozendaal L, Spruyt JWM, F Voorhorst, Beliën JAM, Babovic M, Snijders PJF, and Meijer CJLM. "HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study". BMJ. 2010;340:c1040.
11. Gök M, van Kemenade FJ, Heideman DAM, Berkhof J, Rozendaal L, Spruyt JWM, Beliën JAM, Babovic M, Snijders PJF, and Meijer CJLM. "Experience with high-risk human papillomavirus testing on vaginal brush-based self-samples of non-attendees of the cervical screening program". Int J Cancer J Int Cancer. 2012;130(5):1128-35.
12. Piana L, Leandri F-X, Le Retraite L, Heid P, Tamalet C, Sancho-Garnier H. HPV-Hr detection by home self sampling in women not compliant with pap test for cervical cancer screening. Results of a pilot programme in Bouches-du-Rhône. Bull Cancer (Paris). 2011;98(7):723-31.
13. Sancho-Garnier H, Tamalet C, Halfon P, Leandri FX, Le Retraite L, Djoufelkit K, Heid P, Davies P, and Piana L. "HPV self-sampling or the Pap-smear: a randomized study among cervical screening nonattenders from lower socioeconomic groups in France". Int J Cancer J Int Cancer. 2013;133(11):2681-7.
14. Sanner K, Wikström I, Strand A, Lindell M, Wilander E. Self-sampling of the vaginal fluid at home combined with high-risk HPV testing. Br J Cancer. 2009;101(5):871-4.
15. Virtanen A, Nieminen P, Niironen M, Luostarinen T, Anttila A. Self-sampling experiences among non-attendees to cervical screening. Gynecol Oncol. 2014;135(3):487-94.
16. Bosgraaf RP, Verhoef VMJ, Massuger LFAG, Siebers AG, Bulten J, de Kuyper-de Ridder GM, Meijer CJM, Snijders PJF, Heideman DAM, IntHout J, van Kemenade FJ, Melchers WJG, and Bekkers RLM. Comparative performance of novel self-sampling methods in detecting high-risk human papillomavirus in 30,130 women not attending cervical screening, Int. J. Cancer, p. n/a-n/a, kesäkuu 2014.
17. Virtanen A, Anttila A, Luostarinen T, Malila N, and Nieminen P. Improving cervical cancer screening attendance in Finland, Int. J. Cancer J. Int. Cancer, Sep. 2014.
18. Brink AATP, Meijer CJLM, Wiegerinck MAHM, Nieboer TE, Kruitwagen RFPM, van Kemenade F, van Kemenade F, Fransen Daalmeijer N, Hesselink AT, Berkhof J, and Snijders PJF. "High concordance of results of testing for human papillomavirus in cervicovaginal samples collected by two methods, with comparison of a novel self-sampling device to a conventional endocervical brush". J Clin Microbiol. 2006;44(7):2518-23.
19. Riethmuller D, Gay C, Bertrand X, Bettinger D, Schaal JP, Carbillet JP, Lassabe C, Arveux P, Seilles E, and Mougin C. "Genital human papillomavirus infection among women recruited for routine cervical cancer screening or for colposcopy determined by Hybrid Capture II and polymerase chain reaction". Diagn Mol Pathol Am J Surg Pathol Part B. 1999;8(3):157-64.
20. Working group set up by the Finnish Medical Society Duodecim and the Finnish Colposcopy Association, Cytological changes in the cervix, vagina and vulva. Current Care Guideline. Helsinki, Finland. Available at: www.kaypahoito.fi.
21. Forrest S, McCaffery K, Waller J, Desai M, Szarewski A, Cadman L, and Wardle J. "Attitudes to self-sampling for HPV among Indian, Pakistani, African-Caribbean and white British women in Manchester, UK". J Med Screen. 2004;11(2):85-8.
22. Anhang R, Nelson JA, Telerant R, Chiasson MA, Wright TC. Acceptability of self-collection of specimens for HPV DNA testing in an urban population. J Womens Health 2002. 2005;14(8):721-8.
23. Dzuba IG, Díaz EY, Allen B, Leonard YF, Lazcano Ponce EC, Shah KV, Bishai D, Lorincz A, Ferris D, Turnbull B, Hernández Avila M, and Salmerón J. "The acceptability of self-collected samples for HPV testing vs. the pap test as alternatives in cervical cancer screening". J Womens Health Gend Based Med. 2002;11(3):265-75.
24. Waller J, McCaffery K, Forrest S, Szarewski A, Cadman L, Austin J, and Wardle J. "Acceptability of unsupervised HPV self-sampling using written instructions". J Med Screen. 2006;13(4):208-13.
25. Leinonen MK, Anttila A, Malila N, Dillner J, Forslund O, Nieminen P. Type- and age-specific distribution of human papillomavirus in women attending cervical cancer screening in Finland. Br J Cancer. 2013;109(11):2941-50.
26. Arbyn M, Verdoodt F, Snijders PJF, Verhoef VMJ, Suonio E, Dillner L, Minozzi S, Bellisario C, Banzi R, Zhao F-H, Hillemanns P, and Anttila A. "Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis". Lancet Oncol. 2014;15(2):172-83.
27. Dijkstra MG, Snijders PJF, Arbyn M, Rijkaart DC, Berkhof J, Meijer CJLM. Cervical cancer screening: on the way to a shift from cytology to full molecular screening. Ann Oncol Off J Eur Soc Med Oncol ESMO. 2014;25(5):927-35.
28. Salo H, Nieminen P, Kilpi T, Auranen K, Leino T, Vänskä S, Tiihonen P, Lehtinen M, and Anttila A. "Divergent coverage, frequency and costs of organised and opportunistic Pap testing in Finland". Int J Cancer J Int Cancer. 2014;135(1):204-13.
29. Szarewski A, Cadman L, Ashdown-Barr L, Waller J. Exploring the acceptability of two self-sampling devices for human papillomavirus testing in the cervical screening context: a qualitative study of Muslim women in London. J Med Screen. 2009;16(4):193-8.
30. Barata PC, Mai V, Howlett R, Gagliardi AR, Stewart DE. Discussions about self-obtained samples for HPV testing as an alternative for cervical cancer prevention. J Psychosom Obstet Gynaecol. 2008;29(4):251-7.